PDE10A and glioblastoma: To investigate these observations further, here we have used further growth inhibitors, including two clinical antiproliferative drugs, the PDE10A inhibitor Mardepodect and the multi-kinase inhibitor Regorafenib, profiling them in two additional GBM cell systems.